The MCG Pediatric Podcast
E-cigarettes

E-cigarettes

March 15, 2021

Dr. Alice Caldwell, general pediatrician and member of the AAP Executive Committee on Tobacco Control joins pediatric resident Dr. Kate Peralta, to discuss E-cigarettes and vaping in adolescents.  

 

In this episode we will discuss: 

  1. How national policy has shaped tobacco use and the shift from combustible cigarettes to vaping.
  2. Why E-cigarettes have grown in popularity among youth and young adults.
  3. Side effects of vaping, including nicotine addiction, nicotine withdrawal, other toxins and carcinogens, E-cigarette, or Vaping product use-Associated Lung Injury (EVALI), burns, and explosions 
  4. How primary care clinicians can use the 5As to screen and treat E-cigarette or vape use.
  5. What pharmacotherapy can be used in adolescents to teat nicotine withdrawal. 
  6. Alternative interventions to treat E-cigarette or vape use in adolescents.

Free CME: https://mcg.cloud-cme.com/course/courseoverview?EID=7358&P=3000&CaseID=17 

 

Special thanks to Dr. Lisa Leggio, Dr. Rebecca Yang, and Dr. Zac Hodges for providing peer review for this episode. 

Thank you for listening to this episode from the Department of Pediatrics at the Medical College of Georgia.  

If you have any comments, suggestions, or feedback- please email us at mcgpediatricpodcast@augusta.edu  

Remember that all content during this episode is intended for informational and educational purposes only.  It should not be used as medical advice to diagnose or treat any particular patient.  Clinical vignette cases presented are based on hypothetical patient scenarios 

 

References: 

  1. www.cdc.gov – Youth and Tobacco Use or Current Cigarette Smoking Among Adults in the United States  
  2. E-Cigarettes and Similar Devices. Brian P. Jenssen, Susan C. Walley, SECTION ON TOBACCO CONTROL. Pediatrics Feb 2019, 143 (2) e20183652; DOI: 10.1542/peds.2018-3652 
  3. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. Washington, DC: The National Academies Press; 2018 
  4. US Department of Health and Human Services. E-cigarette Use Among Youth and Young Adults: A Report of the Surgeon General pdf icon . Atlanta, GA: US Department of Health and Human Services, CDC; 2016. Accessed July 27, 2018. 
  5. www.tobaccofreekids.org 
  6. https://www.cancer.org/healthy/stay-away-from-tobacco/guide-quitting-smoking/nicotine-replacement-therapy.html  
  7. https://services.aap.org/en/learning/e-cigarette-curriculum/ 
  8. Gaiha SM, Cheng J, Halpern-Felsher B. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. 2020 Oct;67(4):519-523. doi: 10.1016/j.jadohealth.2020.07.002. Epub 2020 Aug 11. PMID: 32798097; PMCID: PMC7417895. 
  9. https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Richmond-Center/Documents/TobaccoCodingFactSheet.pdf  
  10. https://downloads.aap.org/RCE/Factsheet_Supporting_Youth_Addicted_to_Nicotine.pdf 
  11. Graham AL, Jacobs MA, Amato MS. Engagement and 3-Month Outcomes From a Digital E-Cigarette Cessation Program in a Cohort of 27,000 Teens and Young Adults. Nictotine & Tobacco Research. 2020, 859-960. 
  12. Sanchez S, Kaufman P, Pelletier H, Baskerville B, Feng P, O’Connor S, Schwartz R, Chaiton M. Is vaping cessation like smoking cessation? A qualitative study exploring the responses of youth and young adults who vape e-cigarettes. Addictive Behaviors. 2020. Retrieved from https://doi.org/10.1016/j.addbeh.2020.106687. 

Quitting Resources: 

  • Georgia Tobacco Quit Line: 1-877-270-STOP (7867) or for Spanish speakers: 1-877-2NO-FUME (1-877-266-3862) offers free professional tobacco cessation for Georgia adults, pregnant women and teens (ages 13 and older) + 4-week supply of free Nicotine Replacement Therapy (ages 18 and older)  

 

Multisystem Inflammatory Syndrome in Children (MIS-C)

Multisystem Inflammatory Syndrome in Children (MIS-C)

February 15, 2021

TITLE: Multisystem Inflammatory Disease in Children (MIS-C)

Last Updated: January 22, 2021

PARTICIPANTS:

  • Hosts: Sonal Dugar, Zachary Hodges, Pushpa Shivaram, Julisa Patel
  • Peer Reviewer #1: Smitha Mathew
  • Peer Reviewer #2: Reda Bassali

By the end of listening to this podcast, learners should be able to:

  • Recognize the general clinical presentation of MIS-C.
  • Create a differential diagnosis for children presenting with a non-specific hyperinflammatory syndrome.
  • Recall the CDC case definition of MIS-C.
  • Recall the general approach to the initial evaluation of a patient with possible MIS-C.
  • Compare and contrast the general presentation of MIS-C and Kawasaki disease.
  • Recall the initial treatment of MIS-C including supportive care, IVIG and corticosteroids.
  • Recall that anakinra and other immunomodulating drugs may be indicated for refractory MIS-C.
  • Recognize that aspirin and anticoagulation may be indicated in severe cases of MIS-C.
  • Recall the follow-up required for children with moderate to severe COVID-19 and MIS-C prior to return to normal activities.

Thank you for listening to this episode from the Department of Pediatrics at the Medical College of Georgia.

If you have any comments, suggestions, or feedback- you can email us at mcgpediatricpodcast@augusta.edu

Visit our website at https://www.augusta.edu/mcg/pediatrics/residency/podcast.php for more information and show-notes.

Remember that all content during this episode is intended for informational and educational purposes only.  It should not be used as medical advice to diagnose or treat any particular patient. Clinical vignette cases presented are based on hypothetical patient scenarios. We look forward to speaking to you on our next episode of the MCG Pediatric Podcast.  

 

References:

  1. Godfred-Cato S, Bryant B, Leung J, et al. COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020. MMWR Morb Mortal Wkly Rep 2020;69:1074–1080. DOI: http://dx.doi.org/10.15585/mmwr.mm6932e2external icon
  2. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020;395:1607–8.
  3. Dufort EM, Koumans EH, Chow EJ, et al.; New York State and CDC Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020;383:347–58.
  4. Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383(4):334-346. doi:10.1056/NEJMoa2021680
  5. Whittaker E, Bamford A, Kenny J, et al.; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020;324:259–69.
  6. Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1. Arthritis Rheumatol doi: https://onlinelibrary.wiley.com/doi/10.1002/art.41454.
  7. Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B, Leung JW, Belay ED, Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review, The Journal of Pediatrics (2020), doi: https://doi.org/10.1016/jpeds.2020.08.003.
  8. 1161.CIRCULATIONAHA.120.049836. Review of Cardiac Involvement in MISC. Circulation
  9. Kaushik, Ashlesha MD*; Gupta, Sandeep MD†; Sood, Mangla MD‡; Sharma, Seema MD§; Verma, Shikha MD§ A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection, The Pediatric Infectious Disease Journal: November 2020 - Volume 39 - Issue 11 - p e340-e346 doi: 10.1097/INF.0000000000002888
  10. CDC MIS-C Information Webpage. https://www.cdc.gov/mis-c/cases/index.html
One Pill Can Kill

One Pill Can Kill

January 15, 2021

Did you know that a single tablet from the medicine cabinet or ingestion of a teaspoon of a liquid  household product can potentially cause morbidity and even death in a child? 

 

Dr. Jennifer Tucker, a Pediatric Emergency Physician, joins Dr. Rebecca Yang and Pediatric Resident James Davis to discuss the evaluation and management for specific common but dangerous household medications and substances in the household.  

  • Review the basic assessment skills and evaluation for a child presenting with a potential toxic ingestion 
  • Discuss the role of decontamination, diagnostic options, treatment and monitoring for toxic ingestions 
  • Medications reviewed: Calcium Channel Blockers, Clonidine, Oral Hypoglycemics 
  • Household products reviewed are those that contain toxic alcohols, benzocaine, Imidazoline, Camphor, and methylsalycylate 
  • Anticipatory guidance to families regarding potential exposure/ingestion  

 Special thanks to Dr. George Hsu and Dr. Eric Ring for peer reviewing this episode. 

 

Check out our website for detailed show-notes: https://www.augusta.edu/mcg/pediatrics/residency/podcast.php

Questions, comments, or feedback? Please email us at mcgpediatricpodcast@augusta.edu 

 

References:

  1. Deadly Pediatric Poisons: Nine Common Agents that Kill at Low Doses. MichaelJB, Sztajnkrycer MD. Emerg Med Clin North Am. 2004;22(4):1019–1050
  2. Toxic Ingestions: Initial Management. Courtney W. Mangus, Therese L. Canares. Pediatrics in Review Apr 2018, 39 (4) 219-221
  3. Tucker MD, Jennifer. "One Pill (Or Sip) Can Kill." MCG Pediatric Grand Rounds Presentation. Augusta, Georgia. July 15,2016.

 

IV Fluid Update

IV Fluid Update

December 15, 2020

Pediatric intensivist, Dr. Will Cagle joins the show to discuss the AAP Maintenance IV fluid guidelines and considerations when choosing IV fluids for pediatric inpatients.

What do you need to know from the 2018 AAP maintenance IV fluid guideline? 

How common is hyponatremia in hospitalized patients and why does it matter to your practice? 

What is SIADH and how does it contribute to hyponatremia in acutely ill children? 

How can we prevent hyponatremia in our hospitalized patients? 

What are the differences between hypotonic and isotonic fluids? 

What are balanced solutions and why might they be preferred as compared to saline in some clinical settings? 

All of this and more from the Department of Pediatrics and the Medical College of Georgia. 

Check out our website for detailed show-notes: https://www.augusta.edu/mcg/pediatrics/residency/podcast.php

Special thanks to Dr. Asif Mansuri and Dr. Gene Fisher for providing peer review for this episode.

Questions, comments, or feedback? Please email us at mcgpediatricpodcast@augusta.edu 

Want Further Reading? Check out the clinical practice guideline from the AAP and our other references below.

  • Feld LG, Neuspiel DR, Foster BA, et al. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018;142(6):e20183083. doi:10.1542/peds.2018-3083 
  • Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018;378(9):829-839. doi:10.1056/NEJMoa1711584 
  • Cuzzo B, Padala SA, Lappin SL. Vasopressin (Antidiuretic Hormone, ADH) [Updated 2020 Apr 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526069/ 
  • Chowdhury, Abeed H. BSc, MRCS*; Cox, Eleanor F. PhD; Francis, Susan T. PhD; Lobo, Dileep N. DM, FRCS, FACS* A Randomized, Controlled, Double-Blind Crossover Study on the Effects of 2-L Infusions of 0.9% Saline and Plasma-Lyte® 148 on Renal Blood Flow Velocity and Renal Cortical Tissue Perfusion in Healthy Volunteers, Annals of Surgery: July 2012 - Volume 256 - Issue 1 - p 18-24 doi: 10.1097/SLA.0b013e318256be72 
  • Peti-Peterdi J, Harris RC. Macula densa sensing and signaling mechanisms of renin release. J Am Soc Nephrol. 2010;21(7):1093-1096. doi:10.1681/ASN.2009070759 
  • Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71(3):726-735. doi:10.1172/jci110820 
Kawasaki Disease

Kawasaki Disease

December 1, 2020

Dr. Pushpa Shivaram, an assistant professor of pediatrics and pediatric cardiologist at the Medical College of Georgia, joins Dr. Zac Hodges and Sonal Dugar (M4) to discuss this very important topic in pediatric medicine.

What exactly is Kawasaki disease and why is this topic so important?

How do you make the diagnosis and what other diagnoses should you consider?

How can you diagnosis incomplete Kawasaki when the classic features are not all present?

What is the first-line treatment?

When should you get an echocardiogram?

When should you get your referral center involved?

All of this and more from the Department of Pediatrics and the Medical College of Georgia. 

Check out our website for detailed show-notes: https://www.augusta.edu/mcg/pediatrics/residency/podcast.php

Special thanks to Dr. Reda Bassali, Dr. Leizl Domingo and Dr. Julisa Patel for providing peer review for this episode.

Questions, comments, or feedback? Please email us at mcgpediatricpodcast@augusta.edu 

Further Reading? Check out the clinical practice guideline from the American Heart Association with citation below.

McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association [published correction appears in Circulation. 2019 Jul 30;140(5):e181-e184]. Circulation. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484  

 

 

Bronchiolitis

Bronchiolitis

November 15, 2020

Dr. Reda Bassali, professor of pediatrics and pediatric hospitalist at the Medical College of Georgia, joins Dr. Zac Hodges and Gavriella Mendel (M3) to discuss this very important topic in pediatric medicine.

What exactly is bronchiolitis and why is this topic so important?

How do you make the diagnosis and what other diagnoses should you consider?

What treatments work, and more importantly, which treatments do not?

What patients can go home and who needs to be admitted?

All of this and more from the Department of Pediatrics and the Medical College of Georgia. 

Check out our website for detailed show-notes: https://www.augusta.edu/mcg/pediatrics/residency/podcast.php

Special thanks to Dr. Kathryn McLeod for providing peer review for this episode.

Citation:

Hodges, Z. (Host). Bassali, R. (Host).  Mendel, G. (Host). McLeod, K. (Contributor). (2020, Nov 15). Bronchiolitis. (S1:18) [Audio Podcast Episode]. MCG Pediatric Podcast. Medical College of Georgia Augusta.

Questions, comments, or feedback? Please email us at mcgpediatricpodcast@augusta.edu 

Links: 

NoseFrida-- https://www.nosefrida.com 

References/further reading:

  1. Silver AH, Nazif JM. Bronchiolitis. Pediatr Rev. 2019;40(11):568-576. doi:10.1542/pir.2018-0260  
  2. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis [published correction appears in Pediatrics. 2015 Oct;136(4):782]. Pediatrics. 2014;134(5):e1474-e1502. doi:10.1542/peds.2014-2742 
  3. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017;389(10065):211-224. doi:10.1016/S0140-6736(16)30951-5  
  4. Cunningham S, Rodriguez A, Adams T, et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet. 2015;386(9998):1041-1048. doi:10.1016/S0140-6736(15)00163-4
  5. Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, Furyk J, Fraser JF, Jones M, Whitty JA, Dalziel SR, Schibler A. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. N Engl J Med. 2018 Mar 22;378(12):1121-1131. doi: 10.1056/NEJMoa1714855. PMID: 29562151.
  6. Lin J, Zhang Y, Xiong L, Liu S, Gong C, Dai J. High-flow nasal cannula therapy for children with bronchiolitis: a systematic review and meta-analysis. Arch Dis Child. 2019 Jun;104(6):564-576. doi: 10.1136/archdischild-2018-315846. Epub 2019 Jan 17. PMID: 30655267.
Jude’s Story & 22q11 Deletion Syndrome

Jude’s Story & 22q11 Deletion Syndrome

November 1, 2020

Dr. Charles Scarborough joins the show to discuss the story of his son Jude, and his family's experience with his son's diagnosis with 22q11 deletion syndrome. 

In addition to hearing about the Scarborough's personal experience, we talk about the genetic considerations and common clinical manifestations of 22q11.2 deletion syndrome.

How do you approach the general diagnostic testing and screening evaluation of a child with 22q11.2 deletion syndrome?

We also discuss the impact that genetic and chronic disease has on our pediatric patients and their families.

Thanks to Dr. Paul Mann, Dr. Liezl Domingo and Dr. Jacqueline Chan for providing guidance and peer review of the technical material in this episode. 

Citation:

Hodges, Z. (Host). Scarborough, C. (Host).  Mann, P. (Contributor). Chan, J. (Contributor). Domingo, L. (Contributor).  (2020, Nov 1). Jude’s Story/22q11 Deletion Syndrome. (S1:17) [Audio Podcast Episode]. MCG Pediatric Podcast. Medical College of Georgia Augusta.  

Links:

MCG Pediatric Podcast: https://www.augusta.edu/mcg/pediatrics/residency/podcast.php 

Georgia Medicaid Katie Beckett: https://medicaid.georgia.gov/programs/all-programs/tefrakatie-beckett 

Clinica La fuente in Cusco, Peru http://www.lafuenteclinica.com/clinic-ingles/ 

If you would like to donate to Clinica La fuente https://www.mtw.org/projects/details/pe-la-fuente-centro-de-salud-integral 

 

Questions or comments? Contact us by email at mcgpediatricpodcast@augusta.edu 

 

References:

Cohen JL, Crowley TB, McGinn DE, et al. 22q and two: 22q11.2 deletion syndrome and coexisting conditions. Am J Med Genet A. 2018;176(10):2203-2214. doi:10.1002/ajmg.a.40494

Campbell IM, Sheppard SE, Crowley TB, et al. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. Am J Med Genet A. 2018;176(10):2058-2069. doi:10.1002/ajmg.a.40637

Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, Emanuel BS. MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat. 2006;27(8):814-821. doi:10.1002/humu.20330

McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90(1):1-18. doi:10.1097/MD.0b013e3182060469

Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome.J Pediatr. 2011;159(2):332-9.e1. doi:10.1016/j.jpeds.2011.02.039

Adverse Childhood Experiences (ACEs)

Adverse Childhood Experiences (ACEs)

October 15, 2020

Dr. April Hartman, Dr. Zachary Hodges, and MS4 Rachel Vaizer join the show to discuss adverse childhood experiences and screening for them in the pediatric clinic.

What are the key questions to ask?

What are adverse childhood experiences and how do they affect a child’s long-term health?

How do you bring up the concept of adverse childhood experiences with parents?

How do you screen for ACEs and what do we do with a positive screen at a clinic visit?

 

All of this and more from the Department of Pediatrics at the Medical College of Georgia.

Check out our website: https://www.augusta.edu/mcg/pediatrics/residency/podcast.php

Special thanks to Dr. Lisa Leggio and Dr. Christopher Drescher for providing peer review for this episode.

Citation:

Hodges, Z. (Host). Hartman, A. (Host). Vazier, R. (Host). Leggio, L. (Contributor). Drescher, C. (Contributor). (2020, October 15). Adverse Childhood Events. (S1:16) [Audio Podcast Episode]. MCG Pediatric Podcast. Medical College of Georgia Augusta.  

Questions, comments, or feedback? Please email us at mcgpediatricpodcast@augusta.edu

 

Resources from this episode:

 

 

References for this episode:

Bucci, M., Marques, S. S., Oh, D., & Harris, N. B. (2016). Toxic stress in children and adolescents. Advances in Pediatrics63(1), 403-428.

Felitti V.J. Anda R.F. Nordenberg D. et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) study. Am J Prev Med. 1998; 14: 245-258 

Garner AS, Shonkoff JP, Siegel, B. S., Dobbins, M. I., Earls, M. F., McGuinn, L., Pascoe, J., & Wood, D. L; Committee on Psychosocial Aspects of Child and Family Health; Committee on Early Childhood, Adoption, and Dependent Care; Section on Developmental and Behavioral Pediatrics. Early childhood adversity, toxic stress, and the role of the pediatrician: translating developmental science into lifelong health. Pediatrics. 2012;129(1):e224-e231. doi:10.1542/peds.2011-2662 

Harris, N. B., Marques, S. S., Oh, D., Bucci, M., & Cloutier, M. (2017). Prevent, screen, heal: collective action to fight the toxic effects of early life adversity. Academic pediatrics17(7), S14-S15.  

Kerker B.D. Storfer-Isser A. Szilagyi M. et al. Do pediatricians ask about adverse childhood experiences in pediatric primary care?. Acad Pediatr. 2016; 16: 154-160 

Marie-Mitchell, A., Studer, K. R., & O'Connor, T. G. (2016). How knowledge of adverse childhood experiences can help pediatricians prevent mental health problems. Families, Systems, & Health, 34(2), 128. 

Oh, D. L., Jerman, P., Marques, S. S., Koita, K., Boparai, S. K. P., Harris, N. B., & Bucci, M. (2018). Systematic review of pediatric health outcomes associated with childhood adversity. BMC pediatrics18(1), 83.  

Shonkoff JP, Garner AS; Committee on Psychosocial Aspects of Child and Family Health; Committee on Early Childhood, Adoption, and Dependent Care; Section on Developmental and Behavioral Pediatrics. The lifelong effects of early childhood adversity and toxic stress. Pediatrics. 2012;129(1):e232-e246. doi:10.1542/peds.2011-2663 

Vu, C., Rothman, E., Kistin, C. J., Barton, K., Bulman, B., Budzak-Garza, A., ... & Bair-Merritt, M. H. (2017). Adapting the patient-centered medical home to address psychosocial adversity: results of a qualitative study. Academic pediatrics, 17(7), S115-S122. 

Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents [published correction appears in Pediatrics. 2020 Mar;145(3):]. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 

 

National Center for Injury Prevention and Control, Division of Violence Prevention. (2020, April). Preventing Adverse Childhood Experiences. Retrieved from https://www.cdc.gov/violenceprevention/acestudy/fastfact.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fviolenceprevention%2Fchildabuseandneglect%2Faces%2Ffastfact.html

Sleep Disorders in Children (Part 2)

Sleep Disorders in Children (Part 2)

October 1, 2020

Dr. Katie McKie, a pediatric sleep specialist at the Children's Hospital of Georgia, joins pediatrician Dr. Rebecca Yang to continue their discussion on sleep disorders in the pediatric population.

  • What are the clinical features of restless leg syndrome?
  • What are pharmacologic and alternative options for treatment?
  • When should a patient be referred to a speech specialist?
  • What is a sleep study and what information does it provide?
Special thanks to Dr. Lisa Leggio and Dr. Robert Pendergrast who also contributed to this podcast episode.
 
Citation: 

McKie, K. (Host). Yang, R. (Host). Leggio, L. (Contributor); Pendergrast, R. (Contributor). (2020, October 1). Pediatric Sleep Disorders Part 2. (S1:15) [Audio Podcast Episode]. MCG Pediatric Podcast. Medical College of Georgia Augusta. https://mcgpediatricpodcast.podbean.com/e/sleep-disorders-in-children-part-2/ 

 
Please subscribe, rate and review!
Questions, comments or feedback? Email us at mcgpediatricpodcast@augusta.edu 
 
REFERENCES
  1. Grand Rounds: “Pediatric Insomnia: A Nightmare for Parents and Providers.” Department of Pediatrics, Medical College of Georgia at Augusta University: Katie McKie, MD (Presented on January 10, 2020) 
  2. https://www.sleepfoundation.org/ 
  3. https://www.sleep.org/ 
  4. Moturi S, Avis K. Assessment and treatment of common pediatric sleep disorders. Psychiatry (Edgmont). 2010;7(6):24–37. 
  5. Sumit Bhargava. Diagnosis and Management of Common Sleep Problems in Children. Pediatrics in Review. Mar 2011, 32 (3) 91-99 
Sleep Disorders in Children (Part 1)

Sleep Disorders in Children (Part 1)

September 15, 2020
Dr. Katie McKie, a pediatric sleep specialist at the Children's Hospital of Georgia, joins pediatrician Dr. Rebecca Yang on a two-part series to  discuss the diagnosis and management of sleep disorders in the pediatric population.
  • What is the prevalence of sleep disorders in children?
  • How much sleep does a child need based on developmental stage?
  • How does the general pediatrician screen for sleep disorders?
  • What are clinical features of poor sleep hygiene, behavioral insomnia of childhood, delayed sleep phase syndrome, and chronic insomnia of childhood?
Special thanks to Dr. Lisa Leggio and Dr. Robert Pendergrast who also contributed to this podcast episode.
 
Citation:

McKie, K. (Host). Yang, R. (Host). Leggio, L. (Contributor); Pendergrast, R. (Contributor). (2020, Sept 15). Pediatric Sleep Disorders Part 1. (S1:14) [Audio Podcast Episode]. MCG Pediatric Podcast. Medical College of Georgia Augusta. https://mcgpediatricpodcast.podbean.com/e/sleep-disorders-in-children-part-1/ 

 
Please subscribe, rate and review!
Questions, comments or feedback? Email us at mcgpediatricpodcast@augusta.edu 
 
REFERENCES
  1. Grand Rounds: “Pediatric Insomnia: A Nightmare for Parents and Providers.” Department of Pediatrics, Medical College of Georgia at Augusta University: Katie McKie, MD (Presented on January 10, 2020) 
  2. https://www.sleepfoundation.org/ 
  3. https://www.sleep.org/ 
  4. Moturi S, Avis K. Assessment and treatment of common pediatric sleep disorders. Psychiatry (Edgmont). 2010;7(6):24–37. 
  5. Sumit Bhargava. Diagnosis and Management of Common Sleep Problems in Children. Pediatrics in Review. Mar 2011, 32 (3) 91-99 
Podbean App

Play this podcast on Podbean App